首都医科大学学报 ›› 2009, Vol. 30 ›› Issue (2): 137-141.

• 肾病学专题 • 上一篇    下一篇

174例肾母细胞瘤临床特点及生存分析

蒋也平1, 沈颖1, 孙宁2   

  1. 1. 首都医科大学附属北京儿童医院肾脏内科;2. 首都医科大学附属北京儿童医院泌尿外科
  • 收稿日期:2009-01-18 修回日期:1900-01-01 出版日期:2009-04-21 发布日期:2009-04-21
  • 通讯作者: 沈颖

Clinical Feature and Survival Analysis of 174 Cases with Wilms Tumor

JIANG Ye-ping1, SHEN Ying1, SUN Ning2   

  1. 1. Department of Nephrology, Beijing Children's Hospital, Capital Medical University;2. Department of Urology, Beijing Children's Hospital, Capital Medical University
  • Received:2009-01-18 Revised:1900-01-01 Online:2009-04-21 Published:2009-04-21

摘要: 目的 分析174例肾母细胞瘤患者的临床特点及预后,通过生存分析研究患者手术后死亡时间的分布特点,评价不同临床分期患者的生存率,以期在临床工作中科学评价患者的预后,进一步提高患儿的生存率。方法 对1997年5月~2008年7月在首都医科大学附属北京儿童医院确诊为肾母细胞瘤的174例患者进行回顾性分析,应用Kaplan-Meier法进行生存分析,观察患者临床分期与患者肾母细胞瘤预后的关系。结果 174例肾母细胞瘤患者中77.0%的发病年龄在5岁以下,男女之比为1.72∶ 1.0,以腹部肿物为最常见的临床表现,病理组织类型为FH者占96.9%、UH者占3.1%。术后2年内死亡者占73.3%。术后4年以临床分期生存率Ⅰ期患为97.0%,Ⅱ期为91.3%,Ⅲ期为81.5%,Ⅳ期为70.5%,Ⅴ期仅为62.5%。结论 肾母细胞瘤发病年龄多在5岁以内,无明显性别差异。死亡病例主要发生在术后2年以内。临床分期是影响预后的重要因素,随着临床分期的增加,患者的预期生存率逐渐下降,Ⅰ期患者的预期生存率明显优于Ⅲ期、Ⅳ期、Ⅴ期患者。

关键词: 肾母细胞瘤, 临床分期, 生存分析

Abstract: Objective To analyze the clinical features and prognosis of 174 cases with Wilms tumor, and to investigate the distribution of postoperative time of death and evaluate the survival rate of the patients at different clinical stages, in order to estimate the prognosis scientifically and improve the survival rate of the affected children. Methods A total of 174 Wilms tumor patients who received treatment in Beijing Children's Hospital between May 1997 and July 2008 were analyzed retrospectively. Kaplan-Meier method was used in the evaluation of survival rates to reveal the connections between clinical staging and prognosis. Results The age of onset below 5 years was in 77.0% of the 174 patients, while the male-female ratio was 1.72∶ 1. Most patients complained of abdominal mass, pathologically, FH constituted 96.9% of all cases, while UH constituted 3.1%; 73.3% deaths happened within 2 years, postoperatively. The 4 years survival rate postoperation was predicted to be 97.0% in patients at stage Ⅰ, 91.3% at stage Ⅱ, 81.5% at stage Ⅲ, and 70.5% was at stage Ⅳ, only 62.5% of the patients at stage Ⅴ. Conclusion Wilms' tumor is seen mostly in children at 5 years old or younger. The morbidity of male and female is almost the same. The postoperative death is usually within 2 years. Clinical staging is important for prognosis. A trend of decline in survival rates with the increase in clinical staging has been found. Stage Ⅰ patients' survival rate is significantly higher than that of stages Ⅲ-Ⅴ.

Key words: Wilms tumor, clinical stage, survival analysis

中图分类号: